Recent events
Recent events tied to this brand in public sources.
Back to profile6 entries
2020
Aphria subsidiary receives EU GMP certification
Aphria announced that its subsidiary ARA - Avanti Rx Analytics received EU GMP certification for medicinal products for human use and investigational medicinal products for human use from the Malta Medicines Authority. The certification allows supply to permitted jurisdictions in the European Union.
2020
Aphria reports second-quarter fiscal 2020 results
Aphria reported results for the second quarter ended November 30, 2019, including net revenue of $120.6 million and a net loss of $7.9 million.
2020
Irwin D. Simon becomes Aphria's chief executive officer without interim title
Aphria announced that Irwin D. Simon would officially remove “interim” from his chief executive officer title effective January 14, 2020; he also served as Aphria’s chairman of the board.
2020
Aphria updates fiscal 2020 outlook
Aphria updated its fiscal 2020 guidance, citing market dynamics including slower-than-expected Ontario retail store rollout, a temporary Alberta vape-product ban, higher third-party supply costs, and slower growth at CC Pharma.
2019
Aphria announces executive appointments and promotions
Aphria announced appointments and promotions to its executive leadership team, including Denise Faltischek as chief strategy officer, Tamara Macgregor as chief corporate affairs officer, Megan McCrae as chief marketing officer, and Bernie Yeung as vice president of sales and channel strategy. The appointments were subject to Health Canada security clearances.
2019
Aphria shareholders elect directors
At its annual shareholders' meeting, Aphria elected all seven director nominees, including new director Jodi Butts.